Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Journal of Gastrointestinal Oncology
|
May 9, 2017
Radiation therapy for hepatobiliary malignancies
Jonathan W Lischalk, Michael C Repka, Keith Unger
Cancer Medicine
|
October 6, 2017
Social determinants of stage IV anal cancer and the impact of pelvic radiotherapy in the metastatic setting
Michael C Repka, Nima Aghdam, Andrew W Karlin, et al.
Practical Radiation Oncology
|
April 18, 2024
Target Delineation in Postoperative Radiation Therapy for Head and Neck Cancer After Flap Reconstruction
Xuguang Scott Chen, David J Sher, Christopher Blake Sullivan, et al.
Acta Oncologica (Stockholm, Sweden)
|
February 24, 2023
Dosimetric predictors of acute bowel toxicity after Stereotactic Body Radiotherapy (SBRT) in the definitive treatment of localized prostate cancer
Michael C Repka, Michael Carrasquilla, Ima Paydar, et al.
Journal of Radiation Oncology
|
December 27, 2016
Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC)
Jonathan W Lischalk, Stephanie M Woo, Shaan Kataria, et al.
Cancer Medicine
|
June 9, 2020
Ethnicity and insurance status predict metastatic disease presentation in prostate, breast, and non-small cell lung cancer
Nima Aghdam, Mary McGunigal, Haijun Wang, et al.
Radiation Oncology (London, England)
|
October 21, 2017
Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation
Michael C Repka, Nima Aghdam, Shaan K Kataria, et al.
Advances in Radiation Oncology
|
September 12, 2018
Definitive hypofractionated radiation therapy for early stage breast cancer: Dosimetric feasibility of stereotactic ablative radiotherapy and proton beam therapy for intact breast tumors
Jonathan W Lischalk, Hao Chen, Michael C Repka, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
February 23, 2026
Navigating Variability in Prostate RT Planning: Real-Time Insights for Human-Centered CDS Design
Meagan Foster, Elizabeth Byrd, Elizabeth Kwong, et al.
Advances in Radiation Oncology
|
June 1, 2022
Salvage Prostate Stereotactic Body Radiation Therapy After Definitive Cryoablation
Jonathan W Lischalk, Aaron E Katz, Seth R Blacksburg, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Journal of Gastrointestinal Oncology
|
May 9, 2017
Radiation therapy for hepatobiliary malignancies
Jonathan W Lischalk, Michael C Repka, Keith Unger
Cancer Medicine
|
October 6, 2017
Social determinants of stage IV anal cancer and the impact of pelvic radiotherapy in the metastatic setting
Michael C Repka, Nima Aghdam, Andrew W Karlin, et al.
Practical Radiation Oncology
|
April 18, 2024
Target Delineation in Postoperative Radiation Therapy for Head and Neck Cancer After Flap Reconstruction
Xuguang Scott Chen, David J Sher, Christopher Blake Sullivan, et al.
Acta Oncologica (Stockholm, Sweden)
|
February 24, 2023
Dosimetric predictors of acute bowel toxicity after Stereotactic Body Radiotherapy (SBRT) in the definitive treatment of localized prostate cancer
Michael C Repka, Michael Carrasquilla, Ima Paydar, et al.
Journal of Radiation Oncology
|
December 27, 2016
Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC)
Jonathan W Lischalk, Stephanie M Woo, Shaan Kataria, et al.
Cancer Medicine
|
June 9, 2020
Ethnicity and insurance status predict metastatic disease presentation in prostate, breast, and non-small cell lung cancer
Nima Aghdam, Mary McGunigal, Haijun Wang, et al.
Radiation Oncology (London, England)
|
October 21, 2017
Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation
Michael C Repka, Nima Aghdam, Shaan K Kataria, et al.
Advances in Radiation Oncology
|
September 12, 2018
Definitive hypofractionated radiation therapy for early stage breast cancer: Dosimetric feasibility of stereotactic ablative radiotherapy and proton beam therapy for intact breast tumors
Jonathan W Lischalk, Hao Chen, Michael C Repka, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
February 23, 2026
Navigating Variability in Prostate RT Planning: Real-Time Insights for Human-Centered CDS Design
Meagan Foster, Elizabeth Byrd, Elizabeth Kwong, et al.
Advances in Radiation Oncology
|
June 1, 2022
Salvage Prostate Stereotactic Body Radiation Therapy After Definitive Cryoablation
Jonathan W Lischalk, Aaron E Katz, Seth R Blacksburg, et al.
Page
of 2